Experimental study of anti-gastric cancer effect of combined application of recombinant human endostatin and paclitaxel

QIAN Fei,MA Li-lin,ZHU Jian-wei
2010-01-01
Chinese Journal of Surgical Oncology
Abstract:Objective To explore the anti-cancer effect of combined application of human recombinant endostatin and paclitaxel on human gastric cancer in nude mice,obtain experimental data for further clinical application.Methods Gastric cancer animal model was established by transplantation of cancer tissue to mice stomach,which derived from human gastric cancer cell MKN-45.32 mice with gastric cancer xerograft were divided into 4 groups,subjected to endostatin treatment,paclitaxel treatment,or combined application of the both,in addition,saline solution treatment as the control.Tumor growth,metastasis and ascites formation were recorded for each animal.Moreover,cancer cell apoptosis,tumor MVD and animal serum VEGF/bEGF were examined in order to evaluate the anticancer effect.Results The tumor weight,serum VEGF/bEGF levels and MVD in the combination treatment group were significantly reduced than those in other groups.In addition,the cancer apoptosis rate was remarkably increased in the group.Conclusions It demonstrates that combined application of endostatin and pactlitaxel leads to an enhanced inhibition of the growth and metastasis of gastric cancer,showing a good collaborative anti-cancer effect.
What problem does this paper attempt to address?